Previous work has demonstrated that the gene, Arrdc3,modulates insulin action and glucose metabolism in the liver [54], which may be important for metabolic disorders, including metabolic dysfunction-associated steatotic liver disease. The gene discussed is INS; the disease is liver disorder.